CELC Celcuity Inc
- Stocks
- Healthcare
- NASDAQ: CELC
Price (delayed)
$74.59
Market cap
$3.16B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.47
Enterprise value
$3.22B
Relative Growth:
Rel. Growth:
1
Relative Strength:
Rel. Strength:
99
Relative Valuation:
Rel. Valuation:
N/A
Relative Profitability:
Rel. Profitability:
2
Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia,
Highlights
CELC's net income has plunged by 80% YoY and by 17% from the previous quarter
The equity has plunged by 75% YoY and by 49% from the previous quarter
Key stats
What are the main financial stats of CELC
Market
Valuations
Earnings
Shares outstanding
42.43M
Market cap
$3.16B
Enterprise value
$3.22B
Price to earnings (P/E)
N/A
Price to book (P/B)
63.65
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$146.63M
Net income
-$148.71M
EBIT
-$135.7M
EBITDA
-$135.56M
Free cash flow
-$120.59M
Per share
Balance sheet
Liquidity
EPS
-$3.47
EPS diluted
-$3.47
Free cash flow per share
-$2.76
Book value per share
$1.17
Revenue per share
$0
TBVPS
$4.2
Total assets
$183.59M
Total liabilities
$139.22M
Debt
$99.42M
Equity
$44.38M
Working capital
$143.16M
Debt to equity
2.24
Current ratio
4.58
Quick ratio
4.22
Net debt/EBITDA
-0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-64.7%
Return on equity
-150.1%
Return on invested capital
-50.1%
Return on capital employed
-94.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CELC stock price
How has the Celcuity stock price performed over time
Intraday
2.19%
1 week
0.8%
1 month
47.67%
1 year
389.76%
YTD
469.82%
QTD
50.99%
Financial performance
How have Celcuity's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$146.63M
Net income
-$148.71M
Gross margin
N/A
Net margin
N/A
CELC's net income has plunged by 80% YoY and by 17% from the previous quarter
The operating income has dropped by 72% year-on-year and by 16% since the previous quarter
Price vs fundamentals
How does CELC's price correlate with its fundamentals
Growth
What is Celcuity's growth rate over time
Valuation
What is Celcuity stock price valuation
P/E
N/A
P/B
63.65
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 27% YoY and by 14% QoQ
The equity has plunged by 75% YoY and by 49% from the previous quarter
Efficiency
How efficient is Celcuity business performance
The ROE has plunged by 147% YoY and by 56% from the previous quarter
The return on assets has dropped by 59% year-on-year and by 31% since the previous quarter
Celcuity's return on invested capital has decreased by 38% YoY and by 34% QoQ
Dividends
What is CELC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CELC.
Financial health
How did Celcuity financials performed over time
Celcuity's total assets is 32% more than its total liabilities
The quick ratio has dropped by 71% year-on-year and by 32% since the previous quarter
Celcuity's current ratio has plunged by 69% YoY and by 31% from the previous quarter
The debt is 124% more than the equity
The company's debt to equity has surged by 96% QoQ
The equity has plunged by 75% YoY and by 49% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.